To clarify the regulation of c-Met by Ets-1 in osimertinib-resistant NSCLC cells, we first established cell lines with stable knockdown of Ets-1 and found that silencing Ets-1 downregulated the protein levels of c-Met (Fig. 4D). The gene discussed is MET; the disease is non-small cell lung carcinoma.